Literature DB >> 6771079

Inhibitory effect of heparin on leucocyte chemotactic factors.

B M Czarnetzki, W Panneck, P J Frosch.   

Abstract

Heparin inhibits attraction of leucocytes to chemotactic factors in human skin windows in a dose-dependent fashion. These findings can be reproduced by in vitro chemotaxis studies with zymosan-activated serum, bacterial factor or eosinophil chemotactic factor as chemoattractants. Evidence is presented that the mechanism of this inhibition is an interaction of heparin with the chemotactic factors themselves and not with the migrating leucocytes. Two other mucopolysaccharides, chondroitin sulphate A and hyaluronic acid, are also potent inhibitors of chemotactic factors. These findings suggest a physiological mechanism whereby inflammatory processes can be modulated at tissue sites and within the peripheral circulation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771079      PMCID: PMC1538043     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.

Authors:  E Schiffmann; H V Showell; B A Corcoran; P A Ward; E Smith; E L Becker
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.

Authors:  B M Czarnetzki; W König; L M Lichtenstein
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

3.  Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.

Authors:  W König; B M Czarnetzki; L M Lichtenstein
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

4.  Studies on the mechanisms of hypersensitivity phenomena. XV. Enhancement of passive sensitization of human leukocytes by heparin.

Authors:  D A Levy; A G Osler
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

5.  [In vitro studies on the mode of action and differences to heparin. Anticomplementary effect of a semisynthetic pentosan-polysulfo-ester].

Authors:  D Walb; M Loos; U Hadding
Journal:  Z Naturforsch B       Date:  1971-05       Impact factor: 1.047

6.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

7.  Histamine and heparin release from isolated rat mast cells exposed to compound 48-80.

Authors:  S A Slorach
Journal:  Acta Physiol Scand       Date:  1971-05

8.  Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction.

Authors:  R P Siraganian; W A Hook
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

9.  Role of a peptidase in phagocyte chemotaxis.

Authors:  S Aswanikumar; E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  1 in total

1.  Modulation of locomotor activity of polymorphonuclear cells by cationic substances and cationic lysosomal fractions from human neutrophils.

Authors:  D W Nitzan; W Pruzanski; S Saito; N Ranadive
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.